NEA Management Company »

Athira Pharma shares owned by NEA Management Company

Quarter-by-quarter ownership of Athira Pharma shares owned by NEA Management Company from 13F filings

Historical chart of NEA Management Company investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by NEA Management Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 464k 7.57

More positions owned by NEA Management Company

Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Arcellx Common Stock (ACLX)
Trevi Therapeutics (TRVI)
Savara (SVRA)
Zenas Biopharma (ZBIO)
Monte Rosa Therapeutics (GLUE)
Mbx Biosciences (MBX)
Coursera (COUR)
Aurinia Pharmaceuticals (AUPH)
Gossamer Bio (GOSS)
CRISPR Therapeutics Namen Akt (CRSP)
Oric Pharmaceuticals (ORIC)
Phathom Pharmaceuticals (PHAT)
CVRX (CVRX)

View all positions for NEA Management Company

Top funds holding Athira Pharma

Perceptive Advisors
Acorn Capital Advisors
TCG Crossover Management
Commodore Capital
NEA Management Company
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors

View all funds holding Athira Pharma